FDA Approves First Test to Help Identify Elevated Risk of Opioid Use Disorder

a month ago 7

The AvertD test is a prescription-only genetic test for those 18+ to assess the risk of opioid use disorder using a cheek swab. The post FDA Approves First Test to Help Identify Elevated Risk of Opioid Use Disorder appeared first on DrugTestKitUSA.